Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Relating to the prohibited prescription, delivery, administration, use, advertisement, and solicitation of a COVID-19 vaccine containing mRNA material.
Relating to the licensing and regulation of advanced practice registered nurses and the payment of independent advanced practice registered nurses in certain government employee health plans.
Relating to an advisory board established to develop a resource guide that facilitates collaboration in identifying and addressing local health care workforce needs.